4.3 Editorial Material

Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial

Journal

JOURNAL OF THORACIC DISEASE
Volume 10, Issue 2, Pages 695-698

Publisher

AME PUBL CO
DOI: 10.21037/jtd.2018.01.119

Keywords

-

Funding

  1. National Health and Medical Research Council (NHMRC) of Australia

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available